Skip to main content
logo
Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.410
+0.030 (1.26%)
At close: Aug 24, 2026, 4:00 PM EDT
2.410
0.00 (0.00%)
After-hours: Aug 24, 2026, 6:30 PM EDT

Protalix BioTherapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
80.6252.7453.465.4947.6438.35
Revenue Growth
30.14%-1.23%-18.47%37.48%24.22%-39.03%
Gross Profit
36.96.8616.726.2-0.7922
Operating Income
23.29-5.53.9210.46-13.01-20.46
Net Income
18.95-6.62.938.31-14.93-27.58
Earnings Per Share
0.24-0.080.040.09-0.31-0.62
EPS Growth
205.32%--57.71%---

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Pfizer (Ireland)
11.3318.2312.6212.5212.410.16
Fiocruz (Brazil)
12.0111.0611.0310.49.456.4
Chiesi (Italy)
30.2722.5129.3317.53.440.19
Revenue from License and R&D Services
27.010.940.4225.0822.3521.6
Revenue (Total)
80.6252.7453.465.4947.6438.35

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
40.6630.2734.8344.5622.1838.99
Total Debt
9.218.325.5326.2833.4733.47
Net Cash (Debt)
31.4521.9529.318.28-11.295.52
Net Cash Growth
12.12%-25.09%60.31%---
Net Cash Per Share
0.390.280.360.22-0.230.12

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
9.92-11.998.67-1.32-25-10.29
Capital Expenditures
-2.26-1.64-1.28-1.15-0.63-1.46
Free Cash Flow
7.67-13.637.39-2.47-25.63-11.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.77%13.01%31.27%40.00%-1.65%57.37%
Operating Margin
28.89%-10.43%7.33%15.97%-27.32%-53.36%
Pretax Margin
29.10%-10.63%7.78%13.08%-30.22%-71.92%
Profit Margin
23.50%-12.52%5.49%12.69%-31.33%-71.92%
FCF Margin
9.51%-25.84%13.84%-3.77%-53.80%-30.62%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
10.19-47.2115.62--
Forward PE
-10.293.9413.1760.89111.67
P/FCF Ratio
25.32-18.73---
PS Ratio
2.412.752.591.981.460.99